Example: Heart Attack

Clinical Trials on Shy-Drager Syndrome

Total 118 results

NCT03952806

Active, not recruiting

Study of BHV-3241 in Subjects With Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT02185677

Completed

Cognitive and Behavioral Dysexecutive Syndrome in Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT00750867

Completed

Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins

Conditions: Multiple System Atrophy
NCT04250493

Recruiting

Insulin Resistance in Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT01146548

Completed

Fluoxetine in Multiple System Atrophy Patients

Conditions: Multiple System Atrophy
NCT04287270

Completed

Evaluation of Inspiratory Muscle Strength in Patients With Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT03403309

Completed

Inosine 5'-Monophosphate to Raise of Serum Uric Acid Level in Patients With Multiple System Atrophy: a Multi-center, Randomized Controlled, Double Blind, Parallel Assigned Clinical Trial

Conditions: Multiple System Atrophy
NCT03811808

Recruiting

Multiple System Atrophy Multidisciplinary Clinic

Conditions: Multiple System Atrophy (MSA)
NCT04431713

Recruiting

Exenatide Once-weekly as a Treatment for Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT04165486

Recruiting

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB101 Administered to Adults With Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT03589976

Recruiting

A Futility Trial of Sirolimus in Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT03265444

Completed

Safety and Tolerability of CS10BR05 Inj. in Subjects With Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT04450992

Recruiting

TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT00997672

Terminated

Lithium in Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT01287221

Terminated

Study of Rifampicin in Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT01485549

Completed

Oligomeric Alpha-synuclein in Multiple System Atrophy

Conditions: Multiple System Atrophy (MSA)
NCT04229173

Recruiting

Natural History and Disease Progression Biomarkers of Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT01136213

Completed

Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) Study

Conditions: Multiple System Atrophy
NCT00911365

Completed

Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT00977665

Completed

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Conditions: Multiple System Atrophy
NCT01577992

Completed

Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy

Conditions: Pain Threshold; Multiple System Atrophy
NCT01044992

Completed

Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study

Conditions: Multisystemic Atrophy
NCT02035761

Completed

PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)

Conditions: Multiple System Atrophy - Parkinsonian Subtype (MSA-P); Multiple System Atrophy - Cerebellar Subtype (MSA-C)
NCT04617873

Recruiting

DBS and SCS Therapy Improve Motor Function in Multiple System Atrophy With Predominant Parkinsonism

Conditions: Multiple System Atrophy, Parkinson Variant (Disorder)
NCT03901638

Recruiting

Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System Atrophy

Conditions: Ataxia, Cerebellar; Multiple System Atrophy